ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 95 filers reported holding ODONATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,335,000 | +27.8% | 989 | +175.5% | 0.00% | – |
| Q3 2021 | $1,045,000 | -16.6% | 359 | 0.0% | 0.00% | – |
| Q2 2021 | $1,253,000 | -82.4% | 359 | -82.8% | 0.00% | – |
| Q1 2021 | $7,131,000 | -88.1% | 2,085 | -33.4% | 0.00% | – |
| Q4 2020 | $60,077,000 | +41.2% | 3,129 | -1.2% | 0.00% | – |
| Q3 2020 | $42,533,000 | +84.7% | 3,167 | +482.2% | 0.00% | – |
| Q2 2020 | $23,033,000 | -72.2% | 544 | -81.9% | 0.00% | – |
| Q1 2020 | $82,996,000 | +49.8% | 3,006 | +76.1% | 0.00% | – |
| Q4 2019 | $55,392,000 | +31.0% | 1,707 | +5.1% | 0.00% | – |
| Q3 2019 | $42,273,000 | +34.9% | 1,624 | +90.2% | 0.00% | – |
| Q2 2019 | $31,333,000 | -1.7% | 854 | -40.8% | 0.00% | – |
| Q1 2019 | $31,883,000 | +1921.8% | 1,442 | +1187.5% | 0.00% | – |
| Q4 2018 | $1,577,000 | -62.0% | 112 | -47.7% | 0.00% | – |
| Q3 2018 | $4,154,000 | -12.1% | 214 | 0.0% | 0.00% | – |
| Q2 2018 | $4,725,000 | -81.8% | 214 | -82.6% | 0.00% | – |
| Q1 2018 | $26,030,000 | – | 1,229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 15,514,566 | $297,880,000 | 45.48% |
| Boxer Capital, LLC | 5,607,086 | $107,656,000 | 3.46% |
| Samsara BioCapital, LLC | 815,421 | $15,656,000 | 1.57% |
| GSA CAPITAL PARTNERS LLP | 148,148 | $2,844,000 | 0.46% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,211,728 | $23,265,000 | 0.38% |
| RTW INVESTMENTS, LP | 1,000,139 | $19,203,000 | 0.32% |
| Sio Capital Management, LLC | 75,500 | $1,450,000 | 0.30% |
| AlphaCentric Advisors LLC | 29,594 | $568,000 | 0.24% |
| Birchview Capital, LP | 20,000 | $384,000 | 0.22% |
| Aristides Capital LLC | 33,226 | $638,000 | 0.22% |